Aurélien Amiot , Anthony Buisson , Jean Marc Gornet , Mathurin Fumery , Lucine Vuitton , Pascal Juillerat , Arnaud Bourreille , David Laharie , Guillaume Bouguen , GETAID educational committee
{"title":"Diagnosis and management of patients with Crohn’s disease. Position paper from the GETAID","authors":"Aurélien Amiot , Anthony Buisson , Jean Marc Gornet , Mathurin Fumery , Lucine Vuitton , Pascal Juillerat , Arnaud Bourreille , David Laharie , Guillaume Bouguen , GETAID educational committee","doi":"10.1016/j.clinre.2025.102728","DOIUrl":null,"url":null,"abstract":"<div><div>The therapeutic arsenal for treating Crohn’s disease has grown rapidly, expanding to include advanced therapies with various modes of action. Over the last two decades, physicians and patients have significantly improved the treatment of Crohn’s disease, setting ambitious goals. In 2024, French clinical guidelines were established through a validated process involving the adaptation of international gastroenterology societies' clinical guidelines and French consensus meetings. The French guidelines aimed to ensure the applicability of new approaches in France, taking into account specific restrictions on drug authorization and reimbursement. This position statement outlines the specificity of the French guidelines compared to other international recommendations.</div></div>","PeriodicalId":10424,"journal":{"name":"Clinics and research in hepatology and gastroenterology","volume":"49 10","pages":"Article 102728"},"PeriodicalIF":2.6000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinics and research in hepatology and gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2210740125002050","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/11/1 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The therapeutic arsenal for treating Crohn’s disease has grown rapidly, expanding to include advanced therapies with various modes of action. Over the last two decades, physicians and patients have significantly improved the treatment of Crohn’s disease, setting ambitious goals. In 2024, French clinical guidelines were established through a validated process involving the adaptation of international gastroenterology societies' clinical guidelines and French consensus meetings. The French guidelines aimed to ensure the applicability of new approaches in France, taking into account specific restrictions on drug authorization and reimbursement. This position statement outlines the specificity of the French guidelines compared to other international recommendations.
期刊介绍:
Clinics and Research in Hepatology and Gastroenterology publishes high-quality original research papers in the field of hepatology and gastroenterology. The editors put the accent on rapid communication of new research and clinical developments and so called "hot topic" issues. Following a clear Editorial line, besides original articles and case reports, each issue features editorials, commentaries and reviews. The journal encourages research and discussion between all those involved in the specialty on an international level. All articles are peer reviewed by international experts, the articles in press are online and indexed in the international databases (Current Contents, Pubmed, Scopus, Science Direct).
Clinics and Research in Hepatology and Gastroenterology is a subscription journal (with optional open access), which allows you to publish your research without any cost to you (unless you proactively chose the open access option). Your article will be available to all researchers around the globe whose institution has a subscription to the journal.